Table Of ContentTHERAPEUTIC
MONOCLONAL ANTIBODIES
THERAPEUTIC
MONOCLONAL ANTIBODIES
FROM BENCH TO CLINIC
Editedby
Zhiqiang An
Copyright#2009byJohnWiley&Sons,Inc.Allrightsreserved
PublishedbyJohnWiley&Sons,Inc.,Hoboken,NewJersey
PublishedsimultaneouslyinCanada
Nopartofthispublicationmaybereproduced,storedinaretrievalsystem,ortransmittedinanyformorbyany
means,electronic,mechanical,photocopying,recording,scanning,orotherwise,exceptaspermittedunder
Section107or108ofthe1976UnitedStatesCopyrightAct,withouteitherthepriorwrittenpermissionofthe
Publisher,orauthorizationthroughpaymentoftheappropriateper-copyfeetotheCopyrightClearanceCenter,
Inc.,222RosewoodDrive,Danvers,MA01923,(978)750-8400,fax(978)750-4470,oronthewebatwww.
copyright.com.RequeststothePublisherforpermissionshouldbeaddressedtothePermissionsDepartment,
JohnWiley&Sons,Inc.,111RiverStreet,Hoboken,NJ07030,(201)748-6011,fax(201)748-6008,oronline
athttp://www.wiley.com/go/permission.
LimitofLiability/DisclaimerofWarranty:Whilethepublisherandauthorhaveusedtheirbesteffortsin
preparingthisbook,theymakenorepresentationsorwarrantieswithrespecttotheaccuracyorcompletenessof
thecontentsofthisbookandspecificallydisclaimanyimpliedwarrantiesofmerchantabilityorfitnessfora
particularpurpose.Nowarrantymaybecreatedorextendedbysalesrepresentativesorwrittensalesmaterials.
Theadviceandstrategiescontainedhereinmaynotbesuitableforyoursituation.Youshouldconsultwitha
professionalwhereappropriate.Neitherthepublishernorauthorshallbeliableforanylossofprofitoranyother
commercialdamages,includingbutnotlimitedtospecial,incidental,consequential,orotherdamages.
Forgeneralinformationonourotherproductsandservicesorfortechnicalsupport,pleasecontactour
CustomerCareDepartmentwithintheUnitedStatesat(800)762-2974,outsidetheUnitedStatesat(317)
572-3993orfax(317)572-4002.
Wileyalsopublishesitsbooksinavarietyofelectronicformats.Somecontentthatappearsinprintmaynotbe
availableinelectronicformats.FormoreinformationaboutWileyproducts,visitourwebsiteatwww.wiley.com.
LibraryofCongressCataloging-in-PublicationData:
Therapeuticmonoclonalantibodies:fromthebenchtotheclinic/[editedby]ZhiqiangAn.
p.; cm.
Includesbibliographicalreferencesandindex.
ISBN978-0-470-11791-0(cloth)
1. Monoclonalantibodies—Therapeuticuse. I.An,Zhiqiang,Dr.
[DNLM: 1.Antibodies,Monoclonal—therapeuticuse. 2.DrugDiscovery.
QW575.5.A6T3982009]
RM282.M65T4952009
616.07098—dc22 2008053435
PrintedintheUnitedStatesofAmerica
10 9 8 7 6 5 4 3 2 1
& CONTENTS
FOREWORD ix
PREFACE xi
CONTRIBUTORS xiii
PART I ANTIBODY BASICS
1. TherapeuticMonoclonalAntibodies:Past,Present,andFuture 3
WilliamR.Strohl
2. AntibodyMolecularStructure 51
RobynL.StanfieldandIanA.Wilson
3. GlycosylationofTherapeuticIgGs 67
YusukeMimura,RoyJefferis,YukaMimura-Kimura,JodieAbrahams,andPaulineM.Rudd
w
4. AntibodyDatabasesandTools:TheIMGT Experience 91
Marie-PauleLefranc
PART II ANTIBODY SOURCES
5. HumanAntibodiesfromTransgenicMice 117
NilsLonberg
6. RabbitHybridoma 151
WeiminZhuandGuo-LiangYu
7. HumanAntibodyRepertoireLibraries 169
DavidLoweandTristanJ.Vaughan
PART III IN VITRO DISPLAY TECHNOLOGY
8. AntibodyPhageDisplay 191
MichaelHust,HolgerThie,ThomasSchirrmann,andStefanDu¨bel
v
vi CONTENTS
9. YeastSurfaceDisplay 213
JenniferL.LahtiandJenniferR.Cochran
10. RibosomalDisplay 239
GeorgeThom
11. BacterialDisplayofAntibodies 255
ThomasJ.VanBlarcomandBarrettR.Harvey
12. AntibodySelectionfromImmunoglobulinLibraries
ExpressedinMammalianCells 283
ErnestS.SmithandMauriceZauderer
PART IV ANTIBODY ENGINEERING
13. AntibodyEngineering:Humanization,AffinityMaturation,
andSelectionTechniques 311
JuanC.AlmagroandWilliamR.Strohl
14. ModulationofSerumProteinHomeostasisandTranscytosis
bytheNeonatalFcReceptor 335
WilliamF.Dall’AcquaandHerrenWu
15. EngineeringtheAntibodyFcRegionforOptimal
EffectorFunction 349
GregA.LazarandJohnR.Desjarlais
PART V PHYSIOLOGY AND IN VIVO BIOLOGY
16. Antibody-ComplementInteraction 373
KileenL.MershonandSherieL.Morrison
17. BacteriaImmunoglobulin-BindingProteins:Biology
andPracticalApplications 385
LeslieCopeandTessieMcNeely
18. ImmunogenicityScreeningUsinginSilicoMethods:Correlation
betweenT-CellEpitopeContentandClinicalImmunogenicityof
MonoclonalAntibodies 417
Si-HanHai,JulieA.McMurry,PaulM.Knopf,WilliamMartin,andAnneS.DeGroot
19. MonoclonalAntibodyPharmacokineticsandPharmacodynamics 439
ChristopherR.Gibson,PunamSandhu,andWilliamD.Hanley
20. BiodistributionandImaging 461
ToveOlafsenandAnnaM.Wu
CONTENTS vii
21. AntibodiesandtheBlood-BrainBarrier 483
AngelaR.JonesandEricV.Shusta
PART VI ANTIBODY CHARACTERIZATION
22. DeterminationofEquilibriumDissociationConstants 505
RobinE.Ernst,KatrinaN.High,TomR.Glass,andQinjianZhao
23. MolecularandFunctionalCharacterizationofMonoclonalAntibodies 525
QinjianZhao,TerranceA.Stadheim,LorenzoChen,andMichaelW.Washabaugh
24. CharacterizationofHeterogeneityinMonoclonalAntibodyProducts 541
YangWang,MichaelW.Washabaugh,andQinjianZhao
PART VII ANTIBODY EXPRESSION
25. AntibodyExpressioninMammalianCells 557
FubaoWang,LorenzoChen,NealConnors,andHenrykMach
26. ProductionofAntibodiesinPichiapastoris 573
JuergenH.Nett
27. ProductionofAntibodyFab0 FragmentsinE.coli 589
DavidP.HumphreysandLeighBowering
28. ProductionofHumanTherapeuticMonoclonalAntibodies
inChickenEggs 623
LeiZhuandRobertJ.Etches
29. ProductionofAntibodiesinPlants 651
KevinM.Cox,JeffreyT.Regan,JasonD.Sterling,VincentP.M.Wingate,andLynnF.Dickey
PART VIII THERAPEUTIC ANTIBODIES
30. TheFormulationandDeliveryofMonoclonalAntibodies 675
VikasK.Sharma,Hung-WeiChih,RandallJ.Mrsny,andAnnL.Daugherty
31. TherapeuticAntibodiesinClinicalUseandLeading
ClinicalCandidates 711
NingyanZhang,BrentR.Williams,PingLu,ZhiqiangAn,andChen-NiChin
32. Follow-OnProteinProducts:What,Where,When,How? 763
BrentR.WilliamsandWilliamR.Strohl
33. MonomericFcFusionMolecules 779
JenniferA.Dumont,SusanC.Low,RobertT.Peters,andAlanJ.Bitonti
viii CONTENTS
34. Radioimmunotherapy:CurrentStatusandFutureDirections 797
NeetaPandit-TaskarandChaitanyaR.Divgi
35. Antibody-DrugConjugateTherapy 821
StephenC.Alley,DennisBenjamin,andChe-LeungLaw
ABBREVIATIONS 857
INDEX 865
Description:70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety. Mos